STAT3 and head and neck squamous cell carcinoma: STAT3 is abnormally activated in multiple human solid tumors, including HNSCC.[30] STAT3 has long been considered to be one of the most important therapeutic targets for HNSCC.[31] Our studies identify a new molecular mechanism that regulate STAT3 activation at a post‐translational level through circFAT1.